Summer Road LLC's Form 4 filing
Ocular Therapeutix, Inc (OCUL) · filed Nov 9, 2022
- Accession no.
- 0001567619-22-019384
- Filed
- Nov 9, 2022
- Trade date
- Nov 7, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $25.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Summer Road LLCCIK 0001604873 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2022 | Common Stock, $0.0001 par value per share | PPurchaseAcquired | +7,328 | $3.50F4 | +$25,648 | 6,122,089 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
Represents the weighted average set forth in this line item. On November 7, 2022, the Reporting Person acquired 7,328 shares of Common Stock at a weighted average price of $3.50 (all shares were purchased at a price of $3.50 and therefore no range has been provided). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.